News
BEAT
1.930
-7.66%
-0.160
Weekly Report: what happened at BEAT last week (0408-0412)?
Weekly Report · 5d ago
HeartBeam Presents Results On AI Capabilities For Detecting Arrhythmias
Benzinga · 04/09 13:42
HeartBeam reports positive results of its AI capabilities for detecting arrhythmias
HeartBeam, Inc. Reports positive results of its AI capabilities for detecting arrhythmias. HeartBeam AI with VCG demonstrated a 28% improvement over single-lead ECG in the detection of atrial flutter cases. The company's AI is called StockAI.
Seeking Alpha · 04/09 13:35
HEARTBEAM PRESENTS POSITIVE RESULTS ON ITS ARTIFICIAL INTELLIGENCE CAPABILITIES FOR DETECTING ARRHYTHMIAS
Reuters · 04/09 12:31
Weekly Report: what happened at BEAT last week (0401-0405)?
Weekly Report · 04/08 11:01
Weekly Report: what happened at BEAT last week (0325-0329)?
Weekly Report · 04/01 10:59
Weekly Report: what happened at BEAT last week (0318-0322)?
Weekly Report · 03/25 11:01
Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Shares of FedEx Corporation rose sharply in today’s pre-market trading after the company reported better-than-expected earnings for its third quarter. FedEx reported quarterly earnings of $3.86 per share and authorized a new $5 billion share repurchase program. Nike, Inc. Shares tumbled 6.3% on Thursday after posting upbeat earnings and sales results.
Benzinga · 03/22 12:10
NVFY, BEAT and NTRB are among pre market gainers
On the Move NVFY, BEAT and NTRB are among pre market gainers. Nova Lifestyle (NVFY) and Griid Infrastructure (GRDI) are among the biggest pre market winners. HeartBeam (BEAT) and Fedex (FDX) are also among the top pre market losers.
Seeking Alpha · 03/22 11:53
BEAT Stock Earnings: HeartBeam Meets EPS for Q4 2023
HeartBeam reported earnings per share of -13 cents for the fourth quarter of 2023. The company did not report any revenue for the quarter. HeartBeam met the analyst estimate for EPS of -14 cents. The stock is down 1.7% today.
Investorplace · 03/21 00:53
Heartbeam Inc reports results for the quarter ended in December - Earnings Summary
Heartbeam Inc reports results for the quarter ended in December. The company reported a quarterly adjusted loss of 15 cents per share. Heartbeam Inc shares had fallen by 1.7% this quarter. The average analyst rating on the shares is "buy" for the company.
Reuters · 03/20 21:01
HeartBeam reports Q4 results
HeartBeam, Inc. Reports Q4 results Mar. 20, 2024. Net loss for the fourth quarter of 2023 was $3.9 million. Cash and cash equivalents totaled $16.2 million as of December 31, 2023. HeartBeam stock is down 2.7% in the last day of trading.
Seeking Alpha · 03/20 20:16
Recap: HeartBeam Q4 Earnings
HeartBeam reported its Q4 earnings on March 20. HeartBeam missed estimated earnings by 0.0%. The company is expected to report earnings of $-0.13 per share. The company's revenue was down $0 from the same period last year.
Benzinga · 03/20 20:15
HeartBeam Q4 2023 GAAP EPS $(0.13), Inline
Benzinga · 03/20 20:14
*Heartbeam 4Q Loss $14.6M >BEAT
Dow Jones · 03/20 20:05
*Heartbeam 4Q Loss/Shr 72c >BEAT
Dow Jones · 03/20 20:05
Earnings Scheduled For March 20, 2024
Up Fintech Holding is expected to report quarterly earnings at $0.07 per share on revenue of $207.00 million. Other companies reporting before the bell include Fanhua and Mogo. General Mills is projected to report earnings for its fourth quarter. Vasta Platform is likely to report after the bell.
Benzinga · 03/20 09:32
Weekly Report: what happened at BEAT last week (0311-0315)?
Weekly Report · 03/18 11:00
What's Going On With Heartbeam (BEAT) Stock?
Heartbeam Inc (NASDAQ:BEAT) shares are trading higher by 3.5% to $2.35 Tuesday. The company secured two new patents for its cardiac monitoring technology. HeartBeam has 14 issued US patents and 4 international patents for VECG technology.
Benzinga · 03/12 16:07
Weekly Report: what happened at BEAT last week (0304-0308)?
Weekly Report · 03/11 10:57
More
Webull provides a variety of real-time BEAT stock news. You can receive the latest news about Heartbeam Inc through multiple platforms. This information may help you make smarter investment decisions.
About BEAT
HeartBeam, Inc. is a cardiac technology company. The Company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The Company is engaged in the development of its proprietary and patented Vector Electrocardiography (VECG) technology platform. Its VECG is capable of developing three-dimensional vector images of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It has two patented products in development, such as HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack. HeartBeam AIMIGo is a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms.